Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Seq in Jurkat treated with either PBIT or DMSO

ABSTRACT: RNA-Seq in Jurkat treated with either PBIT or DMSO

PROVIDER: PRJNA689442 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13347762_1.fastq.gz	Fastqsanger.gz
	SRR13347762_2.fastq.gz	Fastqsanger.gz
	SRR13347763_1.fastq.gz	Fastqsanger.gz
	SRR13347763_2.fastq.gz	Fastqsanger.gz
	SRR13347764_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

RNA-Seq in Jurkat treated with either PBIT or DMSO

Project description:To assess whether genes associated with BH4Ds are more or less sensitive than genes associated with sharp H3K4me3 peaks to perturbation of H3K4me3 levels, we performed RNA-Seq experiment from Jurkat cells treated with DMSO or with 2-(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one (PBIT), a specific inhibitor of JARID1 family of H3K4me3 demethylases, also known as KDM5 (Blair et al. 2011; Sayegh et al. 2013).

2021-04-16 | GSE164185 | GEO

ChIP-Seq H3K4me3 in Jurkat treated with either OICR-9429, PBIT or DMSO

Project description:To assess whether BH4Ds are more or less sensitive than sharp H3K4me3 peaks to perturbation of H3K4me3 levels, we performed H3K4me3 ChIP-seq experiments from Jurkat cells treated with DMSO or with either 2-(4-methylphenyl)-1,2-benzisothiazol-3(2H)-one (PBIT), a specific inhibitor of JARID1 family of H3K4me3 demethylases, also known as KDM5, or OICR-9429, an inhibitor of the MLL-WDR5, previously shown to decrease cellular levels of H3K4me3.

2021-04-16 | GSE164184 | GEO

Supplementary Dataset 27 - CHOPPER with DMSO-treated Jurkat cells

Project description:CHOPPER (Chemical enrichment of protease site with purchasable, elutable reagents, an N terminomics method) with DMSO-treated Jurkat cells

2023-02-11 | MSV000091273 | MassIVE

Supplementary Dataset 29 - HUNTER with DMSO-treated Jurkat cells

Project description:HUNTER analysis of N-terminal peptides from Jurkat cells treated with DMSO for 8 h. Control for Supplementary Dataset 28.

2023-06-21 | MSV000092233 | MassIVE

ChIP-Seq H3K4me3 in Jurkat treated with either OICR-9429, PBIT or DMSO

Project description:ChIP-Seq H3K4me3 in Jurkat treated with either OICR-9429, PBIT or DMSO

| PRJNA689441 | ENA

RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

Project description:RNA-seq on DMSO and EPZ6438 treated CD34+ HSPCs

| PRJNA602869 | ENA

Enhanced RNA Interactome capture (eRIC) and RNA Interactome capture (RIC) of Jurkat cells (DSMZ, ACC-282) exposed to 0.5mM DMOG or vehicle (DMSO) for 6 hours.

Project description:1.0 â€“ 1.3 x 10e8 proliferating Jurkat cells at a density of about 1-1.5 x 10e6 cells/mL were employed per sample. Cells were incubated with 0.5mM DMOG (Cayman Chemical Company, 71210) or an equivalent volume of Dimethyl Sulfoxide (DMSO) (vehicle, Merck 1.02950.0500). The DMSO concentration in the medium was 0.023% v/v. Cells were irradiated or not with 254 nm UV light and subjected to eRIC or RIC to determine the RNA-bound proteome. Data correspond to two biologically independent experiments.

2018-09-03 | PXD010942 | Pride

Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO

Project description:To determine changes of gene expression in human CD4+ T cells (Jurkat) infected with HIV-1 and treated with digoxin. Cells were infected (MOI 0.01) with a single cycle HIV-1 delta env expressing GFP and pseudotyoed with VSV-G in the presence of 400nM digoxin or DMSO. Cells were harvested 36 hours post-infection and processed for RNAseq

2017-08-19 | E-MTAB-5982 | biostudies-arrayexpress

RNA-seq of glioma patient tissues treated by DMSO or LY2109761

Project description:RNA-seq of glioma patient tissues treated by DMSO or LY2109761

| PRJNA437873 | ENA

RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO

Project description:RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO

| PRJNA531656 | ENA